Novartis AG Common Stock (NVS)
R&D Expenses
$2.76B
Quarterly · Period ending: · USD
NVS R&D Expenses
Latest reported$2.76Bperiod ending
Latest reported$2.76Bperiod ending
NVS Quarterly R&D Expenses ($0.00 → $2.76B)
Quarterly R&D Expenses
High-resolution chart · PNG
NVS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 560,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 573,000,000 | |
| 0 |